Correction: Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCorrection: Immune Cell and Tumor Cell-derived CXCL10 Is Indicative of Immunotherapy Response in Metastatic Melanoma. BMJ Publishing Group.
MLA (9th ed.) CitationCorrection: Immune Cell and Tumor Cell-derived CXCL10 Is Indicative of Immunotherapy Response in Metastatic Melanoma. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.